GordonMD Global Investments reports $16 million Pyxis Oncology common share purchase
PYXS•GordonMD Global Investments disclosed buying 5,517,000 Pyxis Oncology common shares, bringing its beneficial ownership to 15,541,909 shares. The filing also reports a purchase of 7,546,766 warrants with a $3.50 exercise price; they are not exercisable until stockholder approval increases authorized common shares.
1. Share and warrant purchases
GordonMD Global Investments, a 10% owner of Pyxis Oncology, disclosed purchasing 5,517,000 common shares, bringing its beneficial ownership to 15,541,909 shares held indirectly through GordonMD Long Biased Master Fund. The filing also reports the purchase of 7,546,766 common stock purchase warrants with a $3.50 exercise price; the warrants are not exercisable until stockholder approval increases authorized common shares.
